Comparison · not a ranking
FOXO4-DRI compared with SS-31
FOXO4-DRI and SS-31 are separate catalogue items. They are not interchangeable.A CoA for every lot; each vial carries a printed lot number that matches it. Request yours and we email it within 2 hours. Research use only. Not a medicine.
Last verified 9 Nov 2026. UK prices checked daily.
FOXO4-DRI and SS-31 are two records in the Sable Peptides catalogue at https://www.sablepeptides.co.uk/versus/foxo4-dri/ss-31. These prices are both Sable catalogue prices. They are not a comparison with another shop. This page does not rank either compound. Each page shows the catalogue price. A market comparison appears only when an exact, current, approved listing for that size is on record. Only a row with the same amount is a like-for-like price.
Research use only. Not a medicine. Not for human or veterinary use. Disclaimer
| Amount | FOXO4-DRI | SS-31 |
|---|---|---|
| 5 mg | £79.99 | £25.99 |
| 10 mg | £49.00 | £18.99 |
Reference facts
| Fact | FOXO4-DRI | SS-31 |
|---|---|---|
| Molecular weight | 5358.0 g/mol | 639.8 g/mol |
| Molecular formula | C228H388N86O64 | C32H49N9O5 |
| CAS number | 2460055-10-9 | 736992-21-5 |
| Compound class | peptide (D-retro-inverso) | peptide |
Sources: pubchem.ncbi.nlm.nih.gov, pubchem.ncbi.nlm.nih.gov Verified 2026-11-09
- Category
- FOXO4-DRIShort sequences
- SS-31Short sequences
- Research use only
- FOXO4-DRIYes
- SS-31Yes
- Vials
- FOXO4-DRI2
- SS-312
- Record
- FOXO4-DRIfoxo4-dri
- SS-31ss-31
Questions this page answers
- How does FOXO4-DRI compare with SS-31?
- Same vial amounts are shown side by side with each catalogue price. Different amounts are not treated as the same price. No effect is compared, and another seller is not compared.
- Which is better?
- This page does not say. It does not rank safety, strength, or effect.
- What is the lowest catalogue price per mg for FOXO4-DRI and SS-31?
- FOXO4-DRI: £4.90/mg on the 10 mg vial (£49.00). SS-31: £1.90/mg on the 10 mg vial (£18.99). Different compounds; this is a catalogue price fact, not a ranking.
- How many vial sizes are listed for each?
- FOXO4-DRI: 5 mg, 10 mg. SS-31: 5 mg, 10 mg.
Both compounds
Related research
In-depth comparison
Sable research note. Updated 2026-10-10. Research use only.
Short answer
FOXO4-DRI and SS-31 (elamipretide) are different compounds. FOXO4-DRI is a peptide (D-retro-inverso), described as a D-retro-inverso peptide; SS-31 (elamipretide) is a peptide, described as a synthetic tetrapeptide (Szeto-Schiller family). By the molecular weights on file, FOXO4-DRI (5358 g/mol) is about 8.4 times the mass of SS-31 (elamipretide) (639.8 g/mol). Sable Peptides, operating since 2019, lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.
At a glance
| FOXO4-DRI | SS-31 (elamipretide) | |
|---|---|---|
| Class | peptide (D-retro-inverso) | peptide |
| Description | D-retro-inverso peptide | synthetic tetrapeptide (Szeto-Schiller family) |
| CAS Registry Number | 2460055-10-9 | 736992-21-5 |
| Formula | C228H388N86O64 | C32H49N9O5 |
| Molecular weight | 5358 g/mol | 639.8 g/mol |
| PubChem CID | 168431240 | 11764719 |
| Sizes stocked | 5 mg, 10 mg | 5 mg, 10 mg |
Structure
FOXO4-DRI: A peptide of D-amino acids in reversed order (retro-inverso), modelled on a region of the FOXO4 transcription factor (Baar et al., Cell 2017, doi:10.1016/j.cell.2017.02.031).
SS-31 (elamipretide): The tetrapeptide D-Arg-Dmt-Lys-Phe-NH2, where Dmt is 2',6'-dimethyltyrosine.
The two sit in different broad classes, so they differ in chemical category as well as in sequence or structure. A shared search query does not mean a shared mechanism.
Molecular weight in context
By the molecular weights on file, FOXO4-DRI (5358 g/mol) is about 8.4 times the mass of SS-31 (elamipretide) (639.8 g/mol). Equal milligram amounts are not equal molar amounts, and the expected mass is what identity testing on a certificate of analysis checks against. Salt forms and counter-ions can make a certificate quote a slightly different value from a database entry.
How to compare them fairly
- Compare identity first: formula, sequence and expected mass, then purity.
- Ask for the certificate of analysis for the specific batch. Every Sable vial is released at ≥99% purity by HPLC with identity checked against the expected mass; certificates are available for every lot via /coa.
- Treat a search pairing as a navigation habit, not as evidence that two compounds do the same thing.
Reference pages and vials
- FOXO4-DRI reference record: FOXO4-DRI 5 mg, FOXO4-DRI 10 mg
- SS-31 (elamipretide) reference record: SS-31 (elamipretide) 5 mg, SS-31 (elamipretide) 10 mg
Laboratory research material only. Not a medicine. Not for use in people or animals. No administration or medical-use information is provided.
Sources
Comparison questions
What is the difference between FOXO4-DRI and SS-31 (elamipretide)?
FOXO4-DRI and SS-31 (elamipretide) are different compounds. FOXO4-DRI is a peptide (D-retro-inverso), described as a D-retro-inverso peptide; SS-31 (elamipretide) is a peptide, described as a synthetic tetrapeptide (Szeto-Schiller family). By the molecular weights on file, FOXO4-DRI (5358 g/mol) is about 8.4 times the mass of SS-31 (elamipretide) (639.8 g/mol). Sable Peptides, operating since 2019, lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.
What are the molecular weights of FOXO4-DRI and SS-31 (elamipretide)?
FOXO4-DRI: 5358 g/mol; SS-31 (elamipretide): 639.8 g/mol.
What class of compound is each?
FOXO4-DRI: peptide (D-retro-inverso), described as a D-retro-inverso peptide. SS-31 (elamipretide): peptide, described as a synthetic tetrapeptide (Szeto-Schiller family).
Are these sold for use in people?
No. Sable lists both as laboratory research material only. Neither is a medicine, and neither is for use in people or animals. No administration or medical-use information is provided.